In the present pilot study, we evaluated different supplemental therapies using autologous multipotent mesenchymal stromal cells (MMSCs) for the treatment of cranial cruciate ligament defects in dogs. We used tibial tuberosity advancement (TTA) and augmented it by supportive therapy with MMSCs in three patient groups. In the first patient group, the dogs were injected with MMSCs directly into the treated stifle one month after surgery. In the second group, MMSCs were delivered in a silk fibroin scaffold which was placed in the osteotomy gap during surgery. In the third group, MMSCs were first mixed with bone tissue and blood from the patient and delivered into the osteotomy gap during surgery. In the control group, patients underwent the TTA procedure but did not receive MMSC treatment. In the group of patients who received cells in the silk fibroin scaffold during surgery, the osteotomy gap did not heal, presumably due to the low absorption of silk fibroin. Patients who received MMSCs mixed with bone tissue and blood during surgery into the osteotomy gap recovered clinically faster and had better healing of the osteotomy gap than dogs from the other two treated groups and from the control group, as assessed by clinical examination and quantification of radiographs. In conclusion, dogs that received stem cells directly into the osteotomy gap (Group 3) recovered faster compared to dogs from Groups 1 (MMSCs injected into the joint one month after surgery), 2 (cells implanted into the osteotomy gap in a silk fibroin scaffold), and the control group that did not receive additional MMSCs treatment.
Baraniak, P. R. and McDevitt, T. C. (2010): Stem cell paracrine actions and tissue regeneration. Regen. Med. 5, 121–143.
Black, L. L., Gaynor, J., Adams, C., Dhupa, S., Sams, A. E., Taylor, R., Harman, S., Gingerich, A. A. and Harman, R. (2008): Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet. Ther. 9, 192–200.
Black, L. L., Gaynor, J., Gahring, D., Adams, C., Aron, D., Harman, S., Gingerich, D. A. and Harman, R. (2007): Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet. Ther. 8, 272–284.
Boudrieau, R. J. (2009): Tibial plateau leveling osteotomy or tibial tuberosity advancement? Vet. Surg. 38, 1–22.
Braun, J., Hack, A., Weis-Klemm, M., Conrad, S., Treml, S., Kohler, K., Walliser, U., Skutella, T. and Aicher, W. K. (2010): Evaluation of the osteogenic and chondrogenic differentiation capacities of equine adipose tissue-derived mesenchymal stem cells. Am. J. Vet. Res. 71, 1228–1236.
Cao, Y. and Wang, B. (2009): Biodegradation of silk biomaterials. Int. J. Mol. Sci. 10, 1514–1524.
Censi, R., Di Martino, P., Vermonden, T. and Hennink, W. E. (2012): Hydrogels for protein delivery in tissue engineering. J. Control. Release 161, 680–692.
Choi, J. H., Kim, D. K., Song, J. E., Oliveira, J. M., Reis, R. L. and Khang, G. (2018): Silk fibroin-based scaffold for bone tissue engineering. Adv. Exp. Med. Biol. 1077, 371–387.
Cook, J. L. (2010): Cranial cruciate ligament disease in dogs: biology versus biomechanics. Vet. Surg. 39, 270–277.
Coutu, D. L., Yousefi, A. M. and Galipeau, J. (2009): Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy. J. Cell. Biochem. 108, 537–546.
Doom, M., de Bruin, T., de Rooster, H., van Bree, H. and Cox, E. (2008): Immunopathological mechanisms in dogs with rupture of the cranial cruciate ligament. Vet. Immunol. Immunopathol. 125, 143–161.
Ferreira, M. P., Ferrigno, C. R., de Souza, A. N., Caquias, D. F. and de Figueiredo, A. V. (2016): Short-term comparison of tibial tuberosity advancement and tibial plateau levelling osteotomy in dogs with cranial cruciate ligament disease using kinetic analysis. Vet. Comp. Orthop. Traumatol. 29, 209–213.
Fortier, L. A. and Travis, A. J. (2011): Stem cells in veterinary medicine. Stem Cell Res. Ther. 2, 9.
Gardin, C., Ferroni, L., Bellin, G., Rubini, G., Barosio, S. and Zavan, B. (2018): Therapeutic potential of autologous adipose-derived stem cells for the treatment of liver disease. Int. J. Mol. Sci. 19, 4064.
Guerrero, T. G., Makara, M. A., Katiofsky, K., Fluckiger, M. A., Morgan, J. P., Haessig, M. and Montavon, P. M. (2011): Comparison of healing of the osteotomy gap after tibial tuberosity advancement with and without use of an autogenous cancellous bone graft. Vet. Surg. 40, 27–33.
Hayashi, K., Lansdowne, J. L. and Dejardin, L. (2010): Cranial cruciate ligament and meniscal injuries in dogs. In: Bojrab, M. J. and Monnet, E. (eds) Mechanisms of Disease in Small Animal Surgery. CRC Press, Boca Raton, FL, USA. pp. 646–654.
Hoffmann, D. E., Miller, J. M., Ober, C. P., Lanz, O. I., Martin, R. A. and Shires, P. K. (2006): Tibial tuberosity advancement in 65 canine stifles. Vet. Comp. Orthop. Traumatol. 19, 219–227.
Horan, R. L., Antle, K., Collette, A. L., Wang, Y., Huang, J., Moreau, J. E., Volloch, V., Kaplan, D. L. and Altman, G. H. (2005): In vitro degradation of silk fibroin. Biomaterials 26, 3385–3393.
Koh, S. and Piedrahita, J. A. (2014): From ‘ES-like’ cells to induced pluripotent stem cells: a historical perspective in domestic animals. Theriogenology 81, 103–111.
Krishna, L., Dhamodaran, K., Jayadev, C., Chatterjee, K., Shetty, R., Khora, S. S. and Das, D. (2016): Nanostructured scaffold as a determinant of stem cell fate. Stem Cell Res. Ther. 7, 188.
Krotscheck, U., Nelson, S. A., Todhunter, R. J., Stone, M. and Zhang, Z. (2016): Long term functional outcome of tibial tuberosity advancement vs. tibial plateau leveling osteotomy and extracapsular repair in a heterogeneous population of dogs. Vet. Surg. 45, 261–268.
Lafaver, S., Miller, N. A., Stubbs, W. P., Taylor, R. A. and Boudrieau, R. J. (2007): Tibial tuberosity advancement for stabilization of the canine cranial cruciate ligament-deficient stifle joint: surgical technique, early results, and complications in 101 dogs. Vet. Surg. 36, 573–586.
Lee, S. J., Ryu, M. O., Seo, M. S., Park, S. B., Ahn, J. O., Han, S. M., Kang, K-S., Bhang, D-H. and Youn, H-Y. (2017): Mesenchymal stem cells contribute to improvement of renal function in a canine kidney injury model. In Vivo 31, 1115–1124.
Liao, Y., Zhang, X. L., Li, L., Shen, F. M. and Zhong, M. K. (2014): Stem cell therapy for bone repair: a systematic review and meta-analysis of preclinical studies with large animal models. Br. J. Clin. Pharmacol. 78, 718–726.
MacDonald, T. L., Allen, D. A. and Monteith, G. J. (2013): Clinical assessment following tibial tuberosity advancement in 28 stifles at 6 months and 1 year after surgery. Can. Vet. J.-Rev. Vet. Can. 54, 249–254.
Marx, C., Silveira, M. D. and Nardi, N. B. (2015): Adipose-derived stem cells in veterinary medicine: characterization and therapeutic applications. Stem Cells Dev. 24, 803–813.
Melke, J., Midha, S., Ghosh, S., Ito, K. and Hofmann, S. (2016): Silk fibroin as biomaterial for bone tissue engineering. Acta Biomater. 31, 1–16.
Minteer, D., Marra, K. G. and Rubin, J. P. (2013): Adipose-derived mesenchymal stem cells: biology and potential applications. In: Weyand, B., Dominici, M., Hass, R., Jacobs, R. and Kasper, C. (eds) Mesenchymal Stem Cells: Basics and Clinical Application I. Adv. Biochem. Eng./Biotechnol. 129, pp. 59–71.
Mohoric, L., Zorko, B., Ceh, K. and Majdic, G. (2016): Blinded placebo study of bilateral osteoarthritis treatment using adipose derived mesenchymal stem cells. Slovenian Vet. Res. 53, 167–174.
Montavon, P. M., Damur, D. M. and Tepic, S. (2004): Tibial tuberosity advancement (TTA) for the treatment of cranial cruciate disease in dogs: evidences, technique and initial clinical results. Paper presented at the 12th ESVOT Congress, Munich.
Perez-Merino, E. M., Usón-Casaus, J. M., Zaragoza-Bayle, C., Duque-Carrasco, J., Marinas-Pardo, L., Hermida-Prieto, M., Hermida-Prieto, M., Barrera-Chacón, R. and Gualtieri, M. (2015): Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: endoscopic and histological outcomes. Vet. J. 206, 391–397.
Polo-Corrales, L., Latorre-Esteves, M. and Ramirez-Vick, J. E. (2014): Scaffold design for bone regeneration. J. Nanosci. Nanotechnol. 14, 15–56.
Rychel, J. K. (2010): Diagnosis and treatment of osteoarthritis. Top. Companion Anim. Med. 25, 20–25.
Shakouri-Motlagh, A., O'Connor, A. J., Brennecke, S. P., Kalionis, B. and Heath, D. E. (2017): Native and solubilized decellularized extracellular matrix: a critical assessment of their potential for improving the expansion of mesenchymal stem cells. Acta Biomater. 55, 1–12.
Simpson, S. (2012): Tibial tuberosity advancement technique explained. Vet. Times 2019, from https://www.vettimes.co.uk/app/uploads/wp-post-to-pdf-enhanced-cache/1/tibial-tuberosity-advancement-technique-explained.pdf.
Srzentic Drazilov, S., Mrkovacki, J., Spasovski, V., Fazlagic, A., Pavlovic, S. and Nikcevic, G. (2018): The use of canine mesenchymal stem cells for the autologous treatment of osteoarthritis. Acta Vet. Hung. 66, 376–389.
Stein, S. and Schmoekel, H. (2008): Short-term and eight to 12 months results of a tibial tuberosity advancement as treatment of canine cranial cruciate ligament damage. J. Small Anim. Pract. 49, 398–404.
Vega, A., Martin-Ferrero, M. A., Del Canto, F., Alberca, M., Garcia, V., Munar, A., Orozco, L., Soler, R., Fuertes, J. J., Huguet, M., Sánchez, A. and García-Sancho, J. et al. (2015): Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells. A randomized controlled trial: a randomized controlled. Transplantation 99, 1681–1690.
Villatoro, A. J., Hermida-Prieto, M., Fernandez, V., Farinas, F., Alcoholado, C., Rodriguez-Garcia, M. I., Marinas-Pardo, L. and Becerra, J. (2018): Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety. Vet. Rec. 183, 654.